These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 32437721

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mycosis fungoides and the Sézary syndrome.
    Foss F.
    Curr Opin Oncol; 2004 Sep; 16(5):421-8. PubMed ID: 15314509
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Diagnosis of malignant cutaneous lymphomas].
    Sterry W.
    Dtsch Med Wochenschr; 1988 Feb 05; 113(5):184-9. PubMed ID: 3276493
    [No Abstract] [Full Text] [Related]

  • 5. Bexarotene treatment of late-stage mycosis fungoides and Sézary syndrome: development of extracutaneous lymphoma in 6 patients.
    Bouwhuis SA, Davis MD, el-Azhary RA, McEvoy MT, Gibson LE, Knudsen JM, Kist JM, Pittelkow MR.
    J Am Acad Dermatol; 2005 Jun 05; 52(6):991-6. PubMed ID: 15928617
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Early changes in miRNA expression are predictive of response to extracorporeal photopheresis in cutaneous T-cell lymphoma.
    McGirt LY, Baerenwald DA, Vonderheid EC, Eischen CM.
    J Eur Acad Dermatol Venereol; 2015 Nov 05; 29(11):2269-71. PubMed ID: 24909834
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Cutaneous T-cell lymphoma].
    Dippel E, Gellrich S, Klemke CD, Goerdt S, Sterry W.
    J Dtsch Dermatol Ges; 2003 Dec 05; 1(12):965-80; quiz 981-2. PubMed ID: 16285650
    [No Abstract] [Full Text] [Related]

  • 14. Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas.
    Franceschi J, Ehret M, Visseaux L, Durlach A, Barbe C, Durot É, Grange F.
    Acta Derm Venereol; 2022 Mar 22; 102():adv00676. PubMed ID: 35083494
    [Abstract] [Full Text] [Related]

  • 15. Report of the Committee on Pathology of Cutaneous T Cell Lymphomas.
    Clendenning WE, Rappaport HW.
    Cancer Treat Rep; 1979 Apr 22; 63(4):719-24. PubMed ID: 376141
    [No Abstract] [Full Text] [Related]

  • 16. Sézary Syndrome without erythroderma featuring a CD30+ progression.
    Pileri A, Filippi F, Agostinelli C, Neri I, Patrizi A.
    G Ital Dermatol Venereol; 2019 Aug 22; 154(4):494-495. PubMed ID: 31251008
    [No Abstract] [Full Text] [Related]

  • 17. Cyclosporine in the treatment of cutaneous T cell lymphoma.
    Street ML, Muller SA, Pittelkow MR.
    J Am Acad Dermatol; 1990 Dec 22; 23(6 Pt 1):1084-9. PubMed ID: 2273106
    [Abstract] [Full Text] [Related]

  • 18. CD30 As a Target for the Treatment of Cutaneous T-Cell Lymphoma.
    Prince HM.
    J Clin Oncol; 2015 Nov 10; 33(32):3691-6. PubMed ID: 26392103
    [Abstract] [Full Text] [Related]

  • 19. Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome.
    Zic JA.
    Dermatol Clin; 2015 Oct 10; 33(4):765-76. PubMed ID: 26433848
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.